Martin Bach
Chief Operating Officer at INVITROCUE LIMITED
Profile
Martin Bach is currently working as Vice President-Operations at Invitrocue Ltd.
and Invitrocue Pte Ltd.
He holds a Master's degree in Business Administration from Duale Hochschule Baden-Württemberg Villingen-Schwenningen.
Martin Bach active positions
Companies | Position | Start |
---|---|---|
INVITROCUE LIMITED | Chief Operating Officer | 2016-04-30 |
Invitrocue Pte Ltd.
Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Chief Operating Officer | - |
Training of Martin Bach
Duale Hochschule Baden-Württemberg Villingen-Schwenningen | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Invitrocue Ltd.
Invitrocue Ltd. Medical/Nursing ServicesHealth Services Invitrocue Ltd. engages in the provision of bio analytic solutions including in vitro cell-based testing technologies and image analytics software for use in digital pathology. The firm focuses on the commercialization of its bio analytics services using cell based model and imaging based technology. The company was founded by Steven Fang Boon Sing and Hanry Yu in 2012 and is headquartered in Sydney, Australia. | Health Services |
Invitrocue Pte Ltd.
Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- Martin Bach